Cipla logo. Click to navigate to the home page

  • Home
  • About
    • Company Profile
    • Directorate
    • Vision and Mission
    • Sponsorships
    • Facts
    • Awards
    • Divisions
    • Distribution Centres
    • Partners
    • Brand Ambassadors
    • News
  • Products
    • OTC Products
    • Scheduled Products
  • Media Centre
    • Press Releases
    • Video Library
  • CSI
  • Careers
    • Why work at Cipla
    • Jobs
  • Contact Us
  • Visit Cipla Investor Website
Over-the-counter products
Scheduled Products
  • SOLUS V2 Blood Glucose Management System
  • SOLUS V2 device
  • Alkafizz Granules
  • Gelacid Chewable Tablets / Suspension
  • Betavit AFR capsules
  • Relicalm tablets

  • Allergy
  • Anti-Ageing
  • Asthma
  • Coughs and Colds
  • Diabetes Management
  • Gastrointestinal
  • Pain
  • Sexual Health
  • Skincare
  • Topical
  • Vitamins and Minerals
  • Weight Management
Alkafizz Granules
Reg. No. 29/18.3/0378
S0
Urinary alkaliser, gastric antacid
  • Each 4 g contains:
  • Sodium citrate 0.613 g
  • Citric acid Anhydrous 0.702 g
  • Sodium bicarbonate 1.716 g
  • Tartaric acid 0.858 g
  • Liquid Glucose 0.34 ml
Pack: 60 g / 120 g / 30 sachets
View Video
Package Insert


Return to previous page
Scheduled Products|Over The Counter
Home|About Us|Media Centre|CSI|Careers|Contact Us
Cipla RSS FeedSubscribe to our RSS Newsfeed Cipla on You TubeView Cipla on You Tube
Cipla Investor Relations
© Cipla. All Rights Reserved.
Disclaimer